Sanjivani Paranteral submits rectified audited standalone financial results

12 Jul 2017 Evaluate

With reference to the email dated 10.07.2017, Sanjivani Paranteral has submitted the rectified Audited Standalone Financial Results for the Quarter /year ended March 31, 2017.

The above information is a part of company’s filings submitted to BSE.

Sanjivani Paranteral Share Price

352.90 7.35 (2.13%)
20-Dec-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1808.50
Dr. Reddys Lab 1342.45
Cipla 1472.45
Lupin 2147.55
Zydus Lifesciences 973.90
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.